acetaminophen and dronabinol

acetaminophen has been researched along with dronabinol in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19901 (5.88)18.7374
1990's1 (5.88)18.2507
2000's10 (58.82)29.6817
2010's5 (29.41)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY2
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Andricopulo, AD; Moda, TL; Montanari, CA1
Lombardo, F; Obach, RS; Waters, NJ1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Ahmed, KM; Husain, S1
Flower, RJ1
Bertolini, A; Ferrari, A; Leone, S; Ottani, A; Sandrini, M1
Cichewicz, DL; Haller, VL; Welch, SP1
Stalnikowicz, R1
Ashton, J1
Gabler, M; Schubert-Zsilavecz, M1
Achenbach, JC; Berrue, F; Ellis, LD; Hill, J; McDougall, JJ; Morash, M1
de Kam, ML; Groeneveld, GJ; Hay, JL; Siebenga, P; van Amerongen, G1

Reviews

1 review(s) available for acetaminophen and dronabinol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for acetaminophen and dronabinol

ArticleYear
Effect profile of paracetamol, Δ9-THC and promethazine using an evoked pain test battery in healthy subjects.
    European journal of pain (London, England), 2018, Volume: 22, Issue:7

    Topics: Acetaminophen; Adult; Analgesics, Non-Narcotic; Anti-Allergic Agents; Attention; Cognition; Cold Temperature; Cross-Over Studies; Double-Blind Method; Dronabinol; Female; Healthy Volunteers; Humans; Male; Pain; Pain Measurement; Pain Threshold; Pressure; Promethazine; Young Adult

2018

Other Studies

15 other study(ies) available for acetaminophen and dronabinol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
    Journal of medicinal chemistry, 2002, Jun-20, Volume: 45, Issue:13

    Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding

2002
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
    Journal of medicinal chemistry, 2004, Feb-26, Volume: 47, Issue:5

    Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution

2004
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Hologram QSAR model for the prediction of human oral bioavailability.
    Bioorganic & medicinal chemistry, 2007, Dec-15, Volume: 15, Issue:24

    Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Tissue glutathione levels in mice treated with delta-9-tetrahydrocannabinol.
    Pharmacology, biochemistry, and behavior, 1991, Volume: 40, Issue:3

    Topics: Acetaminophen; Animals; Dronabinol; Glutathione; Male; Mice; Tissue Distribution

1991
Drugs which inhibit prostaglandin biosynthesis.
    Pharmacological reviews, 1974, Volume: 26, Issue:1

    Topics: Acetaminophen; Antioxidants; Arachidonic Acids; Aspirin; Blood Platelets; Dronabinol; Fatty Acids; Hypertension; Indomethacin; Kinetics; Metals; Microsomes; Mixed Function Oxygenases; Oxidoreductases; Prostaglandin Antagonists; Prostaglandins; Salicylates; Species Specificity; Structure-Activity Relationship; Subcellular Fractions; Terminology as Topic; Time Factors

1974
The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors.
    European journal of pharmacology, 2006, Feb-15, Volume: 531, Issue:1-3

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Dose-Response Relationship, Drug; Dronabinol; Male; Morpholines; Nociceptors; Pain Measurement; Pain Threshold; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant

2006
Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.
    European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3

    Topics: Acetaminophen; Amides; Analgesics; Animals; Arachidonic Acids; Benzamides; Benzoquinones; Camphanes; Capsaicin; Carbamates; Dose-Response Relationship, Drug; Dronabinol; Endocannabinoids; Ethanolamines; Hyperalgesia; Male; Mesencephalon; Mice; Mice, Inbred ICR; Narcotic Antagonists; Pain; Palmitic Acids; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid; Rimonabant; Spinal Cord; TRPV Cation Channels

2006
[Practice of toxicology screening in an emergency department].
    Harefuah, 2006, Volume: 145, Issue:10

    Topics: Acetaminophen; Biomarkers; Carboxyhemoglobin; Dronabinol; Emergency Service, Hospital; Humans; Poisoning; Retrospective Studies; Substance Abuse Detection

2006
Pro-drugs for indirect cannabinoids as therapeutic agents.
    Current drug delivery, 2008, Volume: 5, Issue:4

    Topics: Acetaminophen; Amidohydrolases; Animals; Arachidonic Acids; Cannabinoids; Dronabinol; Humans; Pain; Prodrugs

2008
[Mechanism of action of paracetamol--further contribution to discovery].
    Pharmazie in unserer Zeit, 2012, Volume: 41, Issue:4

    Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Biotransformation; Calcium Channels; Dronabinol; Humans; Mice; Nerve Tissue Proteins; Neurotransmitter Agents; Pain; Rats; Receptors, N-Methyl-D-Aspartate; Sodium Channels; Synapses; Transient Receptor Potential Channels; TRPA1 Cation Channel

2012
Comparison of cannabinoids with known analgesics using a novel high throughput zebrafish larval model of nociception.
    Behavioural brain research, 2018, Jan-30, Volume: 337

    Topics: Acetaminophen; Acetic Acid; Analgesics; Animals; Cannabinoid Receptor Agonists; Cannabinoids; Disease Models, Animal; Dose-Response Relationship, Drug; Dronabinol; Ibuprofen; Larva; Locomotion; Nociception; Pain; Principal Component Analysis; Time Factors; Tramadol; Zebrafish

2018